FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Kelderman Kim
  2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [TECH] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Operating Officer
(Last)
(First)
(Middle)
614 MCKINLEY PLACE NE		 3. Date of Earliest Transaction (Month/Day/Year)
11/01/2023
(Street)

MINNEAPOLIS, MN 55413		 4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock               35,421 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $ 37.7               (1) 05/01/2025 Common Stock 27,392   27,392 D  
Stock Option (Right to Buy) $ 44.33               (1) 08/08/2025 Common Stock 84,308   84,308 D  
Stock Option (Right to Buy) $ 47.6               (1) 08/07/2026 Common Stock 109,536   109,536 D  
Stock Option (Right to Buy) $ 66.97               (1) 08/05/2027 Common Stock 69,264   69,264 D  
Stock Option (Right to Buy) $ 66.97               (2) 08/05/2027 Common Stock 47,952   47,952 D  
Restricted Stock Units (3)               (4)   (4) Common Stock 4,980   4,980 D  
Stock Option (Right to Buy) $ 120.46               (4) 08/06/2028 Common Stock 19,456   19,456 D  
Stock Option (Right to Buy) $ 120.46               (5) 08/06/2028 Common stock 25,944   25,944 D  
Restricted Stock Units (3)               (6)   (6) Common Stock 6,984   6,984 D  
Stock Options (Right to Buy) $ 94.52               (6) 08/15/2029 Common Stock 21,704   21,704 D  
Stock Options (Right to Buy) $ 94.52               (7) 08/15/2029 Common Stock 28,940   28,940 D  
Restricted Stock Units (3)               (8)   (8) Common Stock 8,873   8,873 D  
Stock Options (Right to Buy) $ 84.61               (8) 08/15/2030 Common Stock 23,881   23,881 D  
Stock Options (Right to Buy) $ 84.61               (9) 08/15/2030 Common Stock 29,391   29,391 D  
Stock Options (Right to Buy) $ 52.83               (10) 11/01/2030 Common Stock 38,252   38,252 D  
Restricted Stock Units (3) 02/01/2024   A   9,423     (8)   (8) Common Stock 9,423 $ 0 9,423 D  
Stock Options (Right to Buy) $ 68.54 02/01/2024   A   25,945     (8) 02/01/2031 Common Stock 25,945 $ 0 25,945 D  
Stock Options (Right to Buy) $ 68.54 02/01/2024   A   51,890     (11) 02/01/2031 Common Stock 51,890 $ 0 51,890 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Kelderman Kim
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413		       Chief Operating Officer  

Signatures

 /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.   02/05/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Fully exercisable.
(2) Options to purchase 35,964 shares are vested. Options to purchase 11,988 shares vest on 8/5/2024.
(3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
(4) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(5) Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
(6) Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(7) Options to purchase 7,236 shares are vested. Options to purchase 7,236 shares vest on each of 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
(8) Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(9) Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
(10) Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
(11) Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.